Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Beltran Lab
Explore this Website
Home
About Us
Toggle About Us menu options
Contact Us
Job Opportunities
Videos
Affiliations
Research
Lab Team
News
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Affiliations
Research
Lab Team
News
Publications
Home
Publications
Publications
Found 8 results
Author
Title
Type
Year
Filters:
First Letter Of Title
is
N
[Clear All Filters]
2018
Puca L
,
Vlachostergios PJ
,
Beltran H
. 2018.
Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies.
.
Cold Spring Harb Perspect Med.
2017
Pisapia DJ
,
Salvatore S
,
Pauli C
,
Hissong E
,
Eng K
,
Prandi D
,
Sailer V-W
,
Robinson BD
,
Park K
,
Cyrta J
et al.
. 2017.
Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models.
.
JCO Precis Oncol. 2017
2016
Dardenne E
,
Beltran H
,
Benelli M
,
Gayvert K
,
Berger A
,
Puca L
,
Cyrta J
,
Sboner A
,
Noorzad Z
,
MacDonald T
et al.
. 2016.
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer.
.
Cancer Cell. 4(30):563-577.
2014
Beltran H
. 2014.
The N-myc Oncogene: Maximizing its Targets, Regulation, and Therapeutic Potential.
.
Mol Cancer Res. 12(6):815-22.
2013
Beltran H
,
Rubin MA
. 2013.
New strategies in prostate cancer: translating genomics into the clinic.
.
Clin Cancer Res. 19(3):517-23.
2012
Collins CC
,
Volik SV
,
Lapuk AV
,
Wang Y
,
Gout PW
,
Wu C
,
Xue H
,
Cheng H
,
Haegert A
,
Bell RH
et al.
. 2012.
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.
.
Mol Cancer Ther. 11(3):775-83.
Lee DJ
,
Cha EK
,
Dubin JM
,
Beltran H
,
Chromecki TF
,
Fajkovic H
,
Scherr DS
,
Tagawa ST
,
Shariat SF
. 2012.
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).
.
BJU Int. 109(7):968-85.
2011
Beltran H
,
Beer TM
,
Carducci MA
,
de Bono J
,
Gleave M
,
Hussain M
,
Kelly WK
,
Saad F
,
Sternberg C
,
Tagawa ST
et al.
. 2011.
New therapies for castration-resistant prostate cancer: efficacy and safety.
.
Eur Urol. 60(2):279-90.